Szerző:
Summer Crawford, DO1
Jacqueline Schuster, MD2
Saira Kothari, MD3
Whitney Bevis, RN4
Shreeya Patel5
Nigel Pereira, MD6
Steven R. Lindheim, MD, MMM7
1Texas Tech University Health Science Center Permian Basin, Odessa, TX, USA, Department of Obstetrics & Gynecology, Texas Tech Health Science Center Permian Basin, Odessa, TX, USA
2Baylor Scott & White – Baylor College of Medicine, Temple, TX, USA, Department of Obstetrics & Gynecology, Baylor Scott & White – Baylor College of Medicine, Temple, TX, USA
3University of Central Florida/HCA Healthcare GME Consortium of Greater Orlando, Orlando, FL, USA
4Lions World Vision Institute, Tampa, FL, USA
5University of Central Florida College of Medicine, Orlando, Florida, USA, medical student
6Mount Sinai Fertility, Toronto, ON, Canada, Division of Gynecologic Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada
7Department of Obstetrics & Gynecology, University of Central Florida, Orlando, Florida, USA, Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, People’s Republic of China
Medically assisted reproduction (MAR) encompasses established treatments and procedures for infertility including in vitro fertilization (IVF) and third party reproduction using donor sperm, oocytes, and gestational surrogacy. Oocyte donation (OD) is utilized for a number of etiologies, and accounts for 7% to 15% of all reported IVF cycles. The process involves women (recipients) utilizing oocytes donated to them by others, either altruistically ...